Kapha Bio
Startup
United States
Summarized by Halo AI
Kapha Bio is a biotechnology company developing patented biomaterials designed to bolster the body's natural defenses against pathogenic bacteria and address the root causes of recurrent infections.
Founded & HQ
Boston, MA, USA
Company size
1-10 employees
IP status
1 grant confirmed
Activity highlights
Awarded a $305,000 NSF STTR Phase I grant to develop a platform of biomimetic mucins for addressing recurrent infections.
Kapha Bio is a biotechnology company developing patented biomaterials designed to defend against recurrent infections caused by pathogenic bacteria. Their technology focuses on addressing the root causes of these infections, which standard medical treatments often fail to resolve, aiming to improve patient quality of life by preventing the cycle of recurring illness.
AI summary generated on Jun 11, 2026
OpenAlex
OpenAlexFor general inquiries
SL
Sue Levin
Chief Commercial Officer
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.